Shilpa Medicare: Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana
Shilpa Medicare (SHILPAMED) filed a disclosure titled "Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana". The company is valued at about ₹20,053 crore.
What happened
Shilpa Medicare (SHILPAMED) filed a disclosure with the exchanges on 10 October 2026 at 12:40 PM titled "Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana".
Company snapshot
Shilpa Medicare is a small-cap company in the Healthcare sector, with a market value of about ₹20,053 crore.
The stock last traded at ₹1,025.3, against a 52-week range of ₹259.5–₹1,095 (6.4% below the high).
Before this filing the shares had moved +6.8% over the month and +63.5% over three months. Average daily turnover over the last 20 sessions was about ₹86.05 crore.
Promoters held 40.13% at the end of Q1 FY27; 8.73% of promoter shares were pledged. Foreign institutions owned 11.38% and domestic institutions 8.05%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 321 | 46.9 | 4.79 |
| Q2 FY26 | 370 | 44.1 | 2.25 |
| Q3 FY26 | 410 | 44.6 | 2.36 |
| Q4 FY26 | 437 | 107.8 | 5.51 |
| Q1 FY27 | 466 | 100.9 | 5.16 |
What history shows
BCEIE's records show 3 previous approval filings from the company since May 2026.
After those filings, the stock gained 1.7% on average the next trading day and was up 4.2% on average after five days (2 filings with price data).
Across 111 similar disclosures by other Healthcare companies, shares moved +0.5% on average the next day and +1.0% over five days; 51% of them rose the next day.
Market-wide, 1,501 approval filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 18 Sept 2026 | USFDA Inspection of Shilpa Medicare Limited, Unit VII, Analytical… | +1.2% | −0.3% |
| 11 Sept 2026 | A press release dated September 11, 2026, titled "Shilpa Medicare's… | +2.3% | +8.6% |
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.